###begin article-title 0
###xml 63 68 <span type="species:ncbi:9606">Human</span>
DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation
###end article-title 0
###begin p 1
Conceived and designed the experiments: EA DLC AM AT CV SS MB IL VM AB FC. Performed the experiments: EA DLC AM AT CV SS MB IM AL IL FC. Analyzed the data: EA DLC AM AT CV SS MB IM AL IL VM FC. Contributed reagents/materials/analysis tools: DLC MB DF VM GBB. Wrote the paper: EA AB FC.
###end p 1
###begin p 2
paragraph sign These authors also contributed equally to this work.
###end p 2
###begin p 3
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1189 1194 <span type="species:ncbi:10090">mouse</span>
###xml 1264 1269 <span type="species:ncbi:9606">human</span>
Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35. We have previously identified a double homeobox gene (DUX4) within each D4Z4 unit that encodes a transcription factor expressed in FSHD but not control myoblasts. DUX4 and its target genes contribute to the global dysregulation of gene expression observed in FSHD. We have now characterized the homologous DUX4c gene mapped 42 kb centromeric of the D4Z4 repeat array. It encodes a 47-kDa protein with a double homeodomain identical to DUX4 but divergent in the carboxyl-terminal region. DUX4c was detected in primary myoblast extracts by Western blot with a specific antiserum, and was induced upon differentiation. The protein was increased about 2-fold in FSHD versus control myotubes but reached 2-10-fold induction in FSHD muscle biopsies. We have shown by Western blot and by a DNA-binding assay that DUX4c over-expression induced the MYF5 myogenic regulator and its DNA-binding activity. DUX4c might stabilize the MYF5 protein as we detected their interaction by co-immunoprecipitation. In keeping with the known role of Myf5 in myoblast accumulation during mouse muscle regeneration DUX4c over-expression activated proliferation of human primary myoblasts and inhibited their differentiation. Altogether, these results suggested that DUX4c could be involved in muscle regeneration and that changes in its expression could contribute to the FSHD pathology.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 243 246 243 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Hewitt1">[1]</xref>
###xml 247 250 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Wijmenga1">[3]</xref>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 387 391 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 475 478 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lunt1">[4]</xref>
###xml 479 482 479 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanOverveld1">[7]</xref>
###xml 589 592 589 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lemmers1">[8]</xref>
###xml 705 708 705 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lemmers2">[9]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lemmers3">[10]</xref>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
Facioscapulohumeral muscular dystrophy 1A (FSHD1A, OMIM #158900) is the third most frequent hereditary disease of muscle, affecting one individual in 20,000 and is associated with contractions of a repeat array in the subtelomeric 4q35 region [1]-[3]. In non-affected individuals the array comprises 11-100 tandem copies of a 3.3-kilobase (kb) element named D4Z4. In patients, only 1-10 D4Z4 copies are left, and the disease is usually more severe with shorter repeat arrays [4]-[7]. It is chromosome-4 specific since contractions of the homologous repeat array in 10q26 do not cause FSHD [8]. Additional features are also needed on chromosome 4 besides the array contraction since neither the 4qB allele [9] nor some 4qA polymorphic alleles are linked to FSHD [10].
###end p 5
###begin p 6
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanderMaarel1">[11]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanderMaarel2">[12]</xref>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov1">[13]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov1">[13]</xref>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG1</italic>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanDeutekom1">[14]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanGeel1">[15]</xref>
###xml 488 494 488 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TUBB4Q</italic>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanGeel1">[15]</xref>
###xml 527 531 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Rijkers1">[16]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov2">[17]</xref>
###xml 973 977 973 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov1">[13]</xref>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov2">[17]</xref>
###xml 999 1003 999 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 1061 1065 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 1074 1078 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabriels1">[18]</xref>
###xml 1099 1103 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG1</italic>
###xml 1171 1175 1171 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Hanel1">[19]</xref>
###xml 1326 1330 1326 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabellini1">[20]</xref>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 1163 1170 <span type="species:ncbi:8355">Xenopus</span>
###xml 1181 1196 <span type="species:ncbi:10090">transgenic mice</span>
Several genes identified in the region proximal to D4Z4 might contribute to the full FSHD phenotype (reviewed in [11]). Various mechanisms were proposed to explain how the deletion might activate their expression in FSHD muscles (reviewed in [12]; [13]). A FSHD-related nuclear matrix attachment site (FR-MAR) was recently mapped in the locus [13] that establishes a first chromatin loop containing the D4Z4 array and a second 150-kb loop containing FRG1 (FSHD region gene 1) [14], [15], TUBB4Q (a tubulin pseudogene) [15] and FRG2 (FSHD region gene 2) [16]. In addition a very potent transcriptional enhancer was found in the 5'-part of the D4Z4 unit ([17]). The FR-MAR has an enhancer blocking activity that is efficient in human control myoblasts and non-muscle cells. However in FSHD the FR-MAR is weakened so that the repeat array and its neighbouring genes are brought into a single chromatin loop where the D4Z4 enhancer might up-regulate transcription of any gene ([13], [17]) including the DUX4 (double homeobox) gene that our group mapped inside each D4Z4 element [18]. Among those genes, FRG1 was recently shown to be involved in muscle development in Xenopus [19], and transgenic mice that strongly over-express FRG1 in their skeletal muscles present a muscular dystrophy, suggesting an involvement in the disease [20].
###end p 6
###begin p 7
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Kowaljow1">[22]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Bosnakovski1">[23]</xref>
###xml 720 725 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pitx1</italic>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit2">[24]</xref>
###xml 1045 1049 1045 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 1062 1066 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
Our group has shown that DUX4 although initially considered as a pseudogene, was expressed in FSHD but not control primary myoblasts [21]. DUX4 over-expression alters emerin distribution, and induces caspases 3/7 activation leading to death of established cell lines [22]. The DUX4 protein is a transcription factor that can activate or repress numerous genes. Its expression in C2C12 cells recapitulates key features of the FSHD molecular phenotype, including repression of MyoD and its target genes, diminished myogenic differentiation, repression of glutathione redox pathway components, and sensitivity to oxidative stress [23]. One additional DUX4 target is the paired-like homeodomain transcription factor 1 gene (Pitx1) on chromosome 5, that is specifically up-regulated in muscles of patients with FSHD as compared to 11 other neuromuscular disorders [21]. The PITX1 protein in turn activates genes involved in skeletal muscle atrophy that is a hallmark of FSHD [24]. Together these studies provided a link between the genetic defect at D4Z4 (activating DUX4 gene expression) and the pathophysiology of FSHD muscles and thus demonstrated a major role for DUX4 and PITX1 in the disease.
###end p 7
###begin p 8
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Clapp1">[25]</xref>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 264 265 264 265 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</underline>
###xml 260 265 260 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4<underline>c</underline></italic>
###xml 310 314 310 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g001">Fig. 1A</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 415 419 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Wright1">[26]</xref>
###xml 427 434 427 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4S2463</italic>
###xml 497 504 497 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g001">Fig. 1A</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanGeel2">[27]</xref>
###xml 225 230 <span type="species:ncbi:9606">human</span>
The evolutionary conservation of the DUX4 ORF since placental mammals and the presence of several functional paralogues in rodents lend support to a defined function for double homeodomain proteins [25]. We have identified a human DUX4 homologue that we named DUX4c (centromeric) mapping 42 kb proximal of the D4Z4 array, next to the FRG2 gene (Fig. 1A). DUX4c is inside a truncated and inverted solitary D4Z4 unit [26] (locus D4S2463) mapped in 4q35 at the proximal limit of homology with 10q26 (Fig. 1A) [27].
###end p 8
###begin title 9
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
Localization of the DUX4 and DUX4c genes.
###end title 9
###begin p 10
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A4</italic>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1</italic>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-LaoudjChenivesse1">[41]</xref>
###xml 137 140 137 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALP</italic>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Bouju1">[60]</xref>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG1</italic>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanDeutekom1">[14]</xref>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TUBB4Q</italic>
###xml 162 166 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanGeel1">[15]</xref>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Rijkers1">[16]</xref>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4S2463</italic>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov1">[13]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanGeel2">[27]</xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 698 701 698 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
(A) Schematic representation of the 4q35 subtelomeric region with the D4Z4 repeat array and the SLC25A4 (previously known as ANT1) [41], ALP[60], FRG1[14], TUBB4Q[15] and FRG2[16] genes. DUX4 maps within each D4Z4 element [21] and DUX4c within an isolated inverted D4Z4 unit at the D4S2463 locus. S/MAR and FR-MAR: nuclear scaffold/matrix attachment regions, [13]. Upper line: 4q35/10q26 limit of homology [27]. (B) Enlargement (inverted orientation) of the 7.5-kb fragment that contains DUX4c with part of the FRG2 gene. The DUX4c ORF is boxed, with the homeoboxes in black. The promoter GC boxes, the putative variant TATA box (CATAA) and polyadenylation signal are indicated. Numbering from the EcoRI site (GenBank acc. no. AY500824).
###end p 10
###begin p 11
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Bosnakovski2">[28]</xref>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 486 494 486 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 268 273 <span type="species:ncbi:9606">human</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
A previous functional study indicated that the DUX4c protein could interfere with differentiation of mouse C2C12 cells [28]. We have now characterized the endogenous DUX4c gene located near the FSHD locus and shown it was functional. We could detect its expression in human muscle cells (biopsies and primary myoblasts) at RNA and protein levels, and found it was up-regulated in FSHD. DUX4c over-expression could activate human myoblast proliferation and inhibit their differentiation in vitro. This process is most probably caused through induction of the MYF5 myogenic regulator that is up-regulated by DUX4c.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
Characterization of the DUX4c gene
###end title 13
###begin p 14
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG1</italic>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TUBB4Q</italic>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 145 152 145 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g001">Fig. 1A</xref>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
We have identified the DUX4c gene by analysis of a published genomic sequence (GenBank accession no. AF146191) containing FRG1, TUBB4Q and FRG2 (Fig. 1A). Due to the high GC content, we have confirmed its sequence on two different genomic fragments (GenBank accession no. AY500824). DUX4c is identical on a large part of its coding and proximal sequences (including the two homeoboxes) to its DUX4 homologue in D4Z4. The DUX4c ORF is located in a single exon and extends over 1,125 bp as compared to 1,275 for DUX4. Both genes are identical in a 1,137 bp fragment starting 111 bp 5' from their common start codon, except for three mismatches outside the double homeoboxes.
###end p 14
###begin title 15
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
The DUX4c gene contains a functional promoter
###end title 15
###begin p 16
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabriels1">[18]</xref>
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s005">Fig. S1</xref>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pst</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/Eag</italic>
###xml 348 352 348 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3</italic>
###xml 367 377 367 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDUX4c-LUC</italic>
###xml 379 386 379 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g001">Fig. 1B</xref>
###xml 563 566 563 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Luc</italic>
###xml 704 710 704 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g002">Fig. 2</xref>
###xml 459 464 <span type="species:ncbi:10090">mouse</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
A modified TATAA box (TACAA), and a GC box binding Sp1 mediate basal activity of the DUX4 promoter [18]. DUX4c presents similar elements at slightly shifted positions, and an additional GC box (Supplemental Fig. S1). In order to evaluate the DUX4c promoter activity, we fused a 477-bp PstI/EagI upstream fragment to the luciferase reporter gene in pGL3 and generated pDUX4c-LUC (Fig. 1B). The luciferase activity was assayed 24 h after transfection of C2C12 (mouse myoblast), TE671 (human rhabdomyosarcoma) or HeLa cells. As compared to the promoter-less vector (Luc), the luciferase activity was increased 6- and 11-fold in C2C12 and TE671 cells, respectively, but only 1.8-fold in HeLa cells (p<0.01) (Fig. 2).
###end p 16
###begin title 17
Transcriptional activity of the DUX4c gene.
###end title 17
###begin p 18
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 55 56 55 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 222 228 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4 (</italic>
Transcriptional activity of the DUX4c promoter. HeLa, C2C12 and TE671 cells were transfected with pGL3 vectors containing the luciferase reporter gene either promoterless (black bars) or fused to the DUX4c (white bars) or DUX4 (striped bars) promoter. Luciferase activity was measured 24 h post-transfection and expressed relative to the activity of the promoterless vector set to 1. The means and standard errors are indicated (n = 18).
###end p 18
###begin title 19
The DUX4c protein is up-regulated in FSHD primary myoblasts and biopsies
###end title 19
###begin p 20
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 265 272 265 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s006">Fig. S2</xref>
###xml 447 455 447 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 457 463 457 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig 3A</xref>
###xml 490 495 490 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 655 662 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s006">Fig. S2</xref>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 541 547 <span type="species:ncbi:9986">rabbit</span>
Conceptual translation of the DUX4c gene yields a 374-residue protein identical to DUX4 (424 residues) in the double homeo- and most of the carboxyl-terminal domains (positions 1-342). The last 32 residues in DUX4c only present 40% identity with DUX4 (Supplemental Fig. S2). The DUX4 and DUX4c proteins presented apparent molecular weights (MW) of 52 and 47 kDa, respectively, in PAGE-SDS upon expression of their ORF by transcription-translation in vitro (Fig 3A). In order to investigate DUX4c expression in human muscle cells we raised a rabbit antiserum against a carboxyl-terminal peptide present in DUX4c but not in DUX4 (underlined in Supplemental Fig. S2).
###end p 20
###begin title 21
DUX4c protein expression in myoblasts.
###end title 21
###begin p 22
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 110 112 110 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 44 50 <span type="species:ncbi:9986">rabbit</span>
(A) Transcription/translation in vitro in a rabbit reticulocyte lysate in the presence T7 RNA polymerase and [35S]-cysteine with genomic fragments encoding DUX4 (lane 1) or DUX4c (lane 2) cloned in pCIneo. 52 kDa-DUX4 (white arrow) and 47 kDa-DUX4c (black arrow) are detected by autoradiography after 10% PAGE-SDS. (B-C) 30 microg total proteins extracted from primary myoblast were analysed by 4-12% PAGE-SDS and Western blot with the indicated primary antibodies, appropriate secondary antibodies coupled to HRP and the ECL kit. alpha-Tubulin was the loading control. (B) Competition: a 5-fold excess of DUX4c antigenic peptide was pre-incubated (+) or not (-) with the serum raised against DUX4c or cadherin as indicated. (C) Extracts were prepared either from proliferating myoblasts or 2 (d2) or 6 (d6) days after induction of differentiation. (D) DUX4c (red) was detected by immunofluorescence in nuclei of myoblasts and myotubes 2 (d2) and 6 (d6) days after inducing differentiation. a' and b' correspond respectively to two enlarged nuclei from d2 and d6 (white boxes in a and b). The labeling is weakened after competition with the immunogenic peptide (c). Troponin T (green) is a myotube differentiation marker. Myoblasts not fused to myotubes express DUX4c (red nuclei) but not troponin T. Bar corresponds to 20 microm. (E) 30 microg protein extracted from primary myotubes were analyzed by Western blot as in (C). (F) Densitometric scanning of the film shown in (E): DUX4c expression levels were normalized to alpha-Tubulin (relative absorbance units). C: control, F: FSHD, D: DMD.
###end p 22
###begin p 23
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig. 3B</xref>
###xml 274 281 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig. 3B</xref>
###xml 384 390 384 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s007">Fig S3</xref>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig. 3C</xref>
This antiserum revealed a 47-kDa protein in Western blot of both control and FSHD primary myoblasts, but at a higher intensity in the later (Fig. 3B, left panel, lanes F1, F2). This band was specific since it disappeared upon competition with the DUX4c immunogenic peptide (Fig. 3B, right panel) or when the cells were transfected with a siRNA targeting the DUX4c 3'UTR (Supplemental Fig S3). During differentiation (2 and 6 days after confluence), the DUX4c protein progressively accumulated in both control and FSHD myoblasts (Fig. 3C).
###end p 23
###begin p 24
###xml 131 138 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig. 3D</xref>
This antiserum also detected DUX4c by immunofluorescence in the nuclei of primary myotubes, as expected for a homeodomain protein (Fig. 3D; a, enlarged in a'; 2-day differentiation). The punctuate labelling increased during differentiation (b, enlarged in b'; 6-day differentiation) and was lost upon competition with the DUX4c peptide (c). A myoblast subpopulation not included in myotubes also presented labelled nuclei (b, white circle).
###end p 24
###begin p 25
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 256 262 256 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig 3E</xref>
###xml 391 398 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig. 3F</xref>
We then compared DUX4c expression in control, FSHD or Duchenne muscular dystrophy (DMD). Since DUX4c was induced upon differentiation we performed Western blots on extracts of homogenous myotube populations (6-day differentiation) to quantify the protein (Fig 3E) relative to the alpha-tubulin loading control: a 1.5- to 2-fold increase was seen in FSHD as compared to control or DMD cells (Fig. 3F).
###end p 25
###begin p 26
###xml 89 95 89 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g004">Fig 4A</xref>
###xml 446 453 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g004">Fig. 4B</xref>
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 615 622 615 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g004">Fig. 4B</xref>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 943 947 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 1061 1065 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 1234 1238 1234 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lemmers3">[10]</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
###xml 893 900 <span type="species:ncbi:9606">patient</span>
###xml 1035 1043 <span type="species:ncbi:9606">patients</span>
###xml 1119 1126 <span type="species:ncbi:9606">patient</span>
###xml 1215 1223 <span type="species:ncbi:9606">patients</span>
We similarly analysed DUX4c expression in proteins extracted from human muscle biopsies (Fig 4A.) The biopsies were taken in FSHD unaffected quadriceps (Q) or deltoid (D) except for one FSHD affected trapezius (T). Control biopsies were taken in the same muscles of non-affected individuals. The DUX4c signal was quantified relative to the cytochrome C loading control by densitometric analysis of this Western blot and of another one not shown (Fig. 4B). An increased DUX4c level was shown in all FSHD samples with the highest ones detected in the samples derived from patients with low D4Z4 copy numbers (5 or 6; Fig. 4B), except for the F7 sample corresponding to the affected trapezius muscle that presented important necrosis and fat accumulation (data not shown). We observed a progressive DUX4c increase associated to decreasing D4Z4 copy numbers. One of the samples was derived from a patient homozygous for the 4q35 deletion (5 and 7 D4Z4 units) and presented a similar DUX4c level as those found in the biopsies derived from patients with 5 but not 7 D4Z4 units. The nature of the 4q alleles (A or B) in this patient is unknown but only one allele might be pathogenic as reported for two other homozygous patients with FSHD [10]. DUX4c levels were also higher in DMD compared to control biopsies, in contrast to the levels observed in myoblast cultures.
###end p 26
###begin title 27
DUX4c protein expression in muscle biopsies.
###end title 27
###begin p 28
###xml 87 93 83 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig. 3</xref>
###xml 439 443 435 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 543 553 539 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">quadriceps</italic>
###xml 568 577 564 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trapezius</italic>
###xml 469 477 <span type="species:ncbi:9606">patients</span>
(A) 30 microg protein extracted of muscle biopsies were analyzed by Western blot as in Fig. 3, except that cytochrome C was the internal loading control. (B) Densitometric scanning of the Western blot shown in (A) and of additional samples (not shown): DUX4c expression levels were normalized to cytochrome C (relative absorbance units). Samples are indicated C1 to C4 for controls, F1 to F10 for FSHD, and D1 to D4 for DMD as well as the D4Z4 copy numbers of the FSHD patients. The biopsied muscle is indicaded (D, Q: non-affected deltoid or quadriceps; T*: affected trapezius). F10 also has a D4Z4 array contraction on the second 4q35 allele (+7).
###end p 28
###begin title 29
DUX4c over-expression induces MYF5 and cell proliferation
###end title 29
###begin p 30
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 257 263 257 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Ding1">[29]</xref>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 530 539 530 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g005">Fig. 5A&#8211;B</xref>
###xml 542 547 542 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 603 610 603 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g005">Fig. 5C</xref>
###xml 743 750 743 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g005">Fig. 5D</xref>
###xml 870 876 870 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g005">Fig 5E</xref>
###xml 222 227 <span type="species:ncbi:9606">human</span>
We investigated whether DUX4c might affect myogenic factor activities with ELISA-based assays that detect trans-factors upon binding to their immobilized DNA target (TransAm, Active Motif). We prepared nuclear extracts of human TE671 cells transfected with pCIneo vectors expressing DUX4c, DUX4 or the shorter DUX1 protein (a non-4q35 homologue limited to the homeodomains [29]) or with the insert-less vector. Both DUX4c and DUX4 decreased MYOD1 at 24 h (not shown) and 48 h as well as the MEF2 family members evaluated at 48 h (Fig. 5A-B). DUX4c uniquely induced MYF5 binding activity at 24 and 48 h (Fig. 5C, p<0.001). A Western blot demonstrated that MYF5 was induced at the protein level and reached 5- to 6-fold 48 h after transfection (Fig. 5D). This induction was dose-dependent as shown in cells transfected with a doxycyclin-inducible DUX4c expression vector (Fig 5E).
###end p 30
###begin title 31
DUX4c over-expression induces MYF5.
###end title 31
###begin p 32
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 703 715 699 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pAC1M2-DUX4c</italic>
###xml 720 725 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 833 839 829 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 779 784 <span type="species:ncbi:10090">Mouse</span>
(A-C) TE671 cells were transfected with the indicated pCIneo vectors. Nuclear extracts were deposited in triplicate on a plate where the MYOD1, MEF2 or MYF5 specific DNA target was immobilized. The DNA-bound protein was detected by ELISA (TransAm assay). Relative absorbances are given relative to the insertless pCIneo sample arbitrarily set to 1. Three independent experiments (1 to 3) made in triplicate are presented. (D) TE671 nuclear extracts were prepared 48 h after transfection as above and 30 or 15 (*) microg were analyzed by 10% PAGE-SDS and Western blotting with a serum raised against MYF5 or actin (internal control). NT: non transfected cells. (E) same as in D but transfection was with pAC1M2-DUX4c and DUX4c expression induced by doxycycline (o to1000 ng). (F) Mouse C2C12 cells were transfected with the indicated pCIneo vectors. Total protein extracts were prepared 24 or 48 h later and 40 microg were analysed by Western blot with a serum raised against MYF5 or DUX4c as in D. (G) 40 microg nuclear extracts of TE cells transfected with the indicated vectors were subjected to immunoprecipitation with the anti-DUX4c or the anti-MYF5 serum. The immunoprecipitate was analysed by Western blot with the anti-DUX4c or anti-MYF5 serum as in D.
###end p 32
###begin p 33
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Bosnakovski2">[28]</xref>
###xml 233 245 233 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCINeo-DUX4c</italic>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCINeo</italic>
###xml 472 478 472 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g005">Fig 5F</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 452 457 <span type="species:ncbi:9606">human</span>
Intriguingly in another study, the Myf5 mRNA was down-regulated in mouse C2C12 cells expressing an inducible DUX4c cassette [28]. To evaluate whether this discrepancy was caused by species differences we transfected C2C12 cells with pCINeo-DUX4c. Again the Myf5 protein was induced by DUX4c as compared to cells transfected with the insert-less pCINeo vector. Moreover, we could confirm the dose-dependence between DUX4c and Myf5 levels as observed in human muscle cells (Fig 5F).
###end p 33
###begin p 34
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCINeo</italic>
###xml 495 501 495 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g005">Fig 5G</xref>
We then evaluated whether the MYF5 protein might interact with DUX4c. TE671 cells were transfected with pCINeo-DUX4c and protein extracts prepared 48 h later. The immuno-precipitate obtained with an anti-MYF5 serum was loaded on a PAGE-SDS gel and a Western blot was performed with the anti DUX4c serum, showing the expected 47-kDa protein. The protein interaction was confirmed when the immuno-precipitaion was performed with the anti-DUX4c serum and the Western blot with the anti-MYF5 serum (Fig 5G).
###end p 34
###begin p 35
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Buckingham1">[30]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Holterman1">[31]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Zhu1">[32]</xref>
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCINeo</italic>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Kowaljow1">[22]</xref>
###xml 722 731 722 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g006">Fig. 6A,C</xref>
###xml 216 221 <span type="species:ncbi:9606">human</span>
As MYF5 expression and MYOD1 down regulation are related to the maintenance of the muscle satellite cell pool (reviewed by [30], [31]), we investigated whether DUX4c protein expression affected cell proliferation in human TE671 cells or immortalized primary myoblasts [32]. DUX4c induced a 2-3 fold higher proliferation rate than two controls (DUX1 or the insert-less pCINeo vector, p<0.005) as determined with a colorimetric MTT assay 24 and 48 h post transfection. The cells expressing DUX4 had a decreased proliferation rate as expected from its toxicicity [22]. These data were confirmed by total protein quantification and detection of two proliferation markers i.e. PCNA and cyclin A, in the DUX4c expressing cells (Fig. 6A,C).
###end p 35
###begin title 36
DUX4c over-expression induces cell proliferation.
###end title 36
###begin p 37
###xml 82 88 82 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 604 610 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 689 695 689 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 556 561 <span type="species:ncbi:9606">human</span>
###xml 624 629 <span type="species:ncbi:9606">Human</span>
(A) PCNA was detected by immunofluorescence (red) 24 h post transfection with the pCIneo vectors indicated. The picture of DUX4c expressing cells was exposed 1.4 sec versus 2.7 sec for the other panels to visualize the cells. (B) The cells were switched 24 h post transfection to a differentiation medium, and observed 4 days later by phase contrast microscopy (left panels). Early differentiation was evaluated by desmin detection (green, right panels). (C) Cyclin A (green) and DUX4/4c (red) were detected by immunofluorescence 24 h post transfection of human immortalized myoblasts with the indicated pCIneo-vectors. (D) Human immortalized myoblasts were transfected with the indicated pCIneo-vectors and switched to differentiation medium 48 h later. Troponin T was detected by immunofluorescence 8 days later. Bars correspond to 20 microm.
###end p 37
###begin p 38
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g006">Fig. 6B</xref>
###xml 545 557 545 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCI-neoDUX4c</italic>
###xml 619 625 619 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g006">Fig 6D</xref>
###xml 499 504 <span type="species:ncbi:9606">human</span>
We switched the different transfected TE671 cells to a low serum medium to induce differentiation. Four days later, all the cells showed cytoplasmic extensions and high immunofluorescence staining for desmin, an early myogenic differentiation marker, except for the DUX4c expressing cells. These were numerous and smaller and only had a weak labelling for desmin (Fig. 6B). Similarly, at a later time (8-day differentiation) troponin T, another marker of myoblast differentiation, was undetected in human immortalized myoblasts transfected with pCI-neoDUX4c while it was clearly induced in the other transfected cells (Fig 6D).
###end p 38
###begin p 39
In conclusion, forced DUX4c expression induced MYF5 and cell proliferation suggesting a role in myoblast proliferation during muscle regeneration.
###end p 39
###begin title 40
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
Characterization of the endogenous DUX4c mRNAs
###end title 40
###begin p 41
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 284 287 284 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX</italic>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lyle1">[2]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Ding1">[29]</xref>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Beckers1">[33]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Booth1">[35]</xref>
###xml 320 345 320 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s001">Supporting Information S1</xref>
###xml 363 370 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s005">Fig. S1</xref>
###xml 580 587 580 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g007">Fig. 7A</xref>
###xml 757 763 757 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g007">Fig 7B</xref>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 409 414 <span type="species:ncbi:9606">human</span>
###xml 674 679 <span type="species:ncbi:10090">mouse</span>
In the last part of this study, we wanted to characterize the DUX4c mRNAs expressed in human myoblasts. Optimal 5' and 3' RACE conditions were established on mouse C2C12 cells transfected with the DUX4c genomic clones to avoid the background generated by hundreds of homologous human DUX genes [2], [29], [33]-[35] (see Supporting Information S1 and Supplemental Fig. S1). A 5'RACE performed on total RNAs of human primary myoblasts detected 2 and 1 initiation sites in control and FSHD cells, respectively, that might result from the use of either a GC or the variant TATAA box (Fig. 7A). A single DUX4c mRNA end (identical to the most frequent end observed in transfected mouse cells; position 2629) was detected by 3'RACE on total RNA of FSHD myoblasts (Fig 7B). The oligo-dT adapter used for the RT step of the 3'RACE suggested that the mRNAs were polyadenylated although no poly-A addition signal could be identified on the gene.
###end p 41
###begin title 42
Characterization of the DUX4c mRNA.
###end title 42
###begin p 43
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 241 254 241 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p7.5 kb-DUX4c</italic>
###xml 267 292 267 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s002">Supporting Information S2</xref>
###xml 657 670 657 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p7.5 kb-DUX4c</italic>
###xml 738 743 738 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1316 1327 1316 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p3 kb-DUX4c</italic>
(A) Schematic representation of the DUX4c promoter with the transcription start sites (arrows and positions) identified by 5' RACE (primer indicated) on RNA extracted from control and FSHD myoblasts. (B) Top: Schematic representation of the p7.5 kb-DUX4c insert (see Supporting Information S2) close to its 3' cloning site, showing the stop codon, the putative poly-A addition signal, two purine-rich (86 and 83%) regions (black boxes) and the primers used in 3'RACE (arrows, #350 and 351). Bottom: Mapping of the multiple 3' ends and alternative splicing detected in the 3'RACE products. These were derived from RNAs of either C2C12 cells transfected with p7.5 kb-DUX4c or FSHD primary myoblasts (*). (C) Schematic representation of the DUX4c ORF with the homeoboxes (black boxes) and the primers used for RT-PCR. (D) Amplification of the DUX4c mRNA was performed on total RNA extracted from FSHD (F24) or control primary myoblasts (C29) either in proliferation (lanes 4 and 7) or differentiated to myotubes (diff.). RNA samples were incubated (+) or not (-) with DNase I, and reverse transcriptase (RT) as indicated. The PCR products were analysed by electrophoresis on a 1%-agarose gel and stained with ethidium bromide. As a positive control (lane 3), RT-PCR was performed on RNA of C2C12 cells transfected with p3 kb-DUX4c.
###end p 43
###begin p 44
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 192 198 192 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g007">Fig 7C</xref>
###xml 213 221 213 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s003">Table S1</xref>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 371 378 371 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g007">Fig. 7D</xref>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCR4</italic>
###xml 861 868 861 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 916 921 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1084 1089 1084 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 861 868 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Since the DUX4c mRNA ends we mapped were flanking the complete ORF we selected primers to detect the full size mRNA by reverse transcription (RT) with a DUX4c-specific primer followed by PCR (Fig 7C, Supplemental Table S1). The RT-PCR was first performed on total RNAs of C2C12 cells transfected with the DUX4c genomic fragment and yielded the expected 1265-bp fragment (Fig. 7D, lane 3) that was missing upon RT omission or in cells transfected with the insertless vectors (data not shown). A sample not treated with DNase I provided a PCR positive control (lane 1). The 1265-bp RT-PCR product was detected at a very low intensity in a control and an FSHD myoblast line both in proliferation (lanes 4 and 7), and after differentiation to myotubes (lanes 6 and 9). It was absent upon RT omission (lanes 5 and 8). The RT-PCR products were cloned in pCR4 and the E. coli colonies were screened by hybridization with a DUX4c specific probe (see Material and Methods), yielding 30-50% positives. Several of these clones were analyzed and their full cDNA sequences were found identical to DUX4c in either control or FSHD samples.
###end p 44
###begin p 45
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
In aggregate, these data demonstrated that the DUX4c gene could be transcribed from its natural promoter into RNAs covering its entire ORF, and that such mRNAs were expressed in FSHD and control myoblasts.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 134 139 <span type="species:ncbi:9606">human</span>
In the present study, we have characterized the DUX4c gene mapped near the FSHD locus and have demonstrated it expressed a protein in human myoblasts and muscle biopsies.
###end p 47
###begin p 48
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Jiang1">[36]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Alexiadis1">[37]</xref>
###xml 345 350 345 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov1">[13]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Petrov2">[17]</xref>
###xml 459 466 459 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g001">Fig. 1A</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Pirozhkova1">[38]</xref>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 744 748 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 759 764 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1042 1046 1042 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 1052 1073 1052 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 1130 1134 1130 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Alexiadis1">[37]</xref>
###xml 1191 1196 1191 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1426 1431 1426 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 696 701 <span type="species:ncbi:9606">human</span>
Our demonstration of DUX4c mRNA expression confirmed that this 4q35 gene was in a chromatin structure compatible with transcription as suggested by previous studies: its promoter was found associated with acetylated histone H4 [36] and it interacted with RNA polymerase II at slightly higher level than non-transcribed sequences [37]. Moreover, DUX4c is brought in the same chromatin loop as the enhancer-containing D4Z4 repeats in FSHD myoblasts [13], [17]; Fig. 1A) and this enhancer directly interacts with the DUX4c promoter [38]. However, these publications had failed to detect DUX4c mRNAs by RT-PCR. Our present study is the first report detecting the endogenous DUX4c mRNA and protein of human muscle cells. Similarly to the homologous DUX4 mRNA, the DUX4c sequence is extremely GC-rich and difficult to retro-transcribe and amplify. We have recently listed the critical technical points to amplify these low-abundance and GC rich mRNAs, and highlighted the need for a higher temperature and a gene-specific primer during the RT step [21] (see Materials and Methods). An additional problem in the study by Alexiadis et al [37] is that the forward primer used to specifically amplify DUX4c hybridized at position 777-800, i.e. upstream of some of the 5' ends found in the present study. Indeed, our 5'RACE data suggested that transcription could be driven as well by the variant TATAA box as by several GC boxes in the DUX4c promoter.
###end p 48
###begin p 49
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
In the DUX4c gene, a single exon comprised the full ORF, and we found a spliced out intron in the 3' untranslated region (UTR) of some mRNAs. No polyadenylation signal could be found on the gene and the DUX4c mRNAs presented heterogeneous 3' ends. Such a structure was reported for histone genes that use the U7 snRNA to process the mRNA ends (37). However, the 3'RACE was done with an oligo-dT primer suggesting a polyadenylation of the DUX4c mRNAs.
###end p 49
###begin p 50
###xml 221 227 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TUBB4Q</italic>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanGeel1">[15]</xref>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG1</italic>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Rijkers1">[16]</xref>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabellini2">[39]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Jiang1">[36]</xref>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Winokur1">[40]</xref>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ANT1</italic>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC25A4</italic>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Jiang1">[36]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-LaoudjChenivesse1">[41]</xref>
###xml 171 176 <span type="species:ncbi:9606">human</span>
The studies of gene transcription in 4q35 are complicated by the fact these genes belong to families with functional or pseudogene homologues in multiple locations of the human genome. No transcript could be detected for TUBB4Q[15], some studies found increased FRG1 and FRG2 mRNAs in FSHD samples [16], [39], others did not [36], [40]. The only protein expression data were reported for DUX4 present within each D4Z4 repeated element [21] and for ANT1 (also called SLC25A4) located 4.9 Mb from the locus. The ANT1 protein was strongly upregulated in contrast to its mRNA, suggesting a posttranscriptional regulation [36], [41].
###end p 50
###begin p 51
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Pirozhkova1">[38]</xref>
###xml 377 381 377 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 497 501 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 516 523 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g004">Fig. 4B</xref>
###xml 593 597 593 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 646 651 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 651 655 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabellini2">[39]</xref>
###xml 983 987 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 1006 1011 1006 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1060 1064 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 716 724 <span type="species:ncbi:9606">patients</span>
###xml 967 975 <span type="species:ncbi:9606">patients</span>
Y. Vassetsky's group showed that an enhancer located in D4Z4 interacts directly with the DUX4c promoter as a result of changes in chromatin looping caused by the D4Z4 array contraction [38]. In agreement with this observation, we detected that the DUX4c protein was increased in extracts of FSHD muscles. Moreover, a progressive DUX4c accumulation was associated to decreasing D4Z4 copy numbers, with DUX4c expression reaching 10-fold the control value when the pathogenic allele only presented 5 D4Z4 units (F8-F10 Fig. 4B). A similar activation pattern was previously shown for the flanking FRG2 gene that belongs to the same chromatin loop as DUX4c[39]. The DUX4c increase was observed in non-affected muscles of patients suggesting it was an early event in the disease progression. DUX4c expression could therefore be considered as a sensor of chromatin structure in FSHD. It would be very interesting to evaluate DUX4c expression in biopsies of the few reported patients with a D4Z4 deletion removing DUX4c (see below) or of asymptomatic individuals with D4Z4 deletion to confirm this hypothesis.
###end p 51
###begin p 52
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 194 203 194 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trapezius</italic>
###xml 227 237 227 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">quadriceps</italic>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabellini2">[39]</xref>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 815 818 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanOverveld1">[7]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Butz1">[42]</xref>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-LaoudjChenivesse1">[41]</xref>
###xml 924 928 924 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Celegato1">[43]</xref>
###xml 508 516 <span type="species:ncbi:9606">patients</span>
No link between DUX4c expression and D4Z4 copy number could be observed in myoblasts. However the only primary myoblast line with 5 units we used derived from the F7 biopsy taken in an affected trapezius, not in a non-affected quadriceps like the other samples. The relationship between DUX4c expression and D4Z4 copy number in muscle biopsies is in agreement with a transcriptional inhibitory role of the D4Z4 element [39] and should be further evaluated in additional samples from different muscles and in patients with lower D4Z4 copy numbers. We could not correlate DUX4c protein expression and residual D4Z4 copy number (5 to 8) to clinical disease severity in the present study. This is in agreement with previous data for which such a correlation could not be established for D4Z4 arrays larger than 3 units [7], [42]. The DUX4c protein has not been observed by other groups in proteome studies of FSHD muscles [41], [43] most probably because its very high pI (11.1) was not reached during the isoelectrofocalisation step.
###end p 52
###begin p 53
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Kitzmann1">[44]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Yamane1">[45]</xref>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Holterman1">[31]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Bosnakovski2">[28]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Doucet1">[46]</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 582 587 <span type="species:ncbi:9606">human</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
Forced DUX4c expression in human muscle cells induced the MYF5 protein and its DNA-binding activity. This transcription factor is known to inhibit myoblast differentiation [44], [45]. Furthermore, DUX4c expression inhibited MYOD1 DNA-binding activity and prevented cell differentiation following serum withdrawal, as reported for Myf5+/MyoD- myoblasts [31] and in iC2C12-DUX4c cells [28]. The later study reported a down-regulation of the Myf5 mRNA following DUX4c induction. In contrast, in the present report, we observed a dose-dependent induction of the Myf5 protein as well in human TE671 as in mouse C2C12 cells expressing DUX4c. In addition, we found an interaction between DUX4c and Myf5 that might lead to a stabilisation of the later protein. Indeed Myf5 degradation is known to be controlled by specific posttranslational modifications [46] and it is therefore possible that deregulation of the mRNA does not lead to change in the protein levels.
###end p 53
###begin p 54
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-GayraudMorel1">[47]</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Ustanina1">[48]</xref>
###xml 450 459 450 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g004">Fig. 4A&#8211;B</xref>
###xml 536 540 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Haslett1">[49]</xref>
###xml 727 734 727 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g004">Fig. 4B</xref>
###xml 1030 1036 1030 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig 3E</xref>
###xml 1122 1130 1122 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s004">Table S2</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
Besides an interference with myoblast differentiation that was also described by Bosnakovski et al (2008), we found that DUX4c over-expression in human cells led to an increased proliferation rate by MTT assay, PCNA and cyclin A labelling. This phenomenon could be due to MYF5 protein accumulation since its absence was shown to reduce the proliferation rate of satellite cell derived myoblasts [47], [48]. The DUX4c increase in DMD muscle biopsies (Fig. 4A-B) could be related to the higher regeneration rate reported for this disease [49]. The DMD biopsies used in the present study indeed contained newly formed fibres still presenting centrally located nuclei (data not shown). The DUX4c up-regulation in the DMD biopsies (Fig. 4B) could be related to the increased satellite cell proliferation in comparison to control muscles where satellite cells were quiescent. In keeping with this idea, no difference in DUX4c expression was found between DMD and control myoblasts that were both derived from activated satellite cells (Fig 3E). In contrast to FSHD, DMD muscles do not present D4Z4 contraction (see Supplemental Table S2) therefore DUX4c up-regulation could only be related to increased muscle regeneration.
###end p 54
###begin p 55
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Nicolas1">[50]</xref>
The up-regulation of DUX4c expression upon myoblast differentiation and its inhibitory effect on this very process appear contradictory. However one could hypothesize that DUX4c has different function in myoblasts or in myotubes according to its interaction with different protein partners. Indeed its MYF5 partner which is involved in proliferation is only expressed in myoblasts but not in myotubes [50]. Moreover the observed change of DUX4c nuclear localization during differentiation is in favour of a functional switch.
###end p 55
###begin p 56
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pitx1</italic>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Coppe1">[51]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-KawamuraSaito1">[52]</xref>
###xml 546 550 546 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Kowaljow1">[22]</xref>
Functional studies performed in parallel on the homologous DUX4c and DUX4 proteins have shown several differences despite their high similarity. Both proteins share an identical double homeodomain and specifically bind the Pitx1 promoter but DUX4 activates its transcription at a stronger level [21]. DUX4 does indeed present a carboxyl terminal region partly missing in DUX4c that mediates strong transcriptional activation [51], [52]. Forced DUX4c expression in TE671 cells did not induce caspases 3/7 activity nor cell death as shown for DUX4 [22] (A. Marcowycz, unpublished data). Moreover, we found that the MYF5 induction was unique to DUX4c expression.
###end p 56
###begin p 57
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 223 226 223 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lemmers1">[8]</xref>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D4Z4</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Lemmers4">[53]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-vanderMaarel2">[12]</xref>
###xml 587 591 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 663 667 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Rijkers1">[16]</xref>
###xml 726 731 726 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 812 817 812 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 935 940 935 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1002 1007 1002 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 1012 1016 1012 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FRG2</italic>
###xml 886 894 <span type="species:ncbi:9606">patients</span>
The DUX4c gene is only present on chromosome 4 where it defines the proximal limit of homology with chromosome 10, and our results suggest it plays a role in FSHD that is uniquely associated with array contractions in 4q35 [8]. However, a deletion extending from the D4Z4 repeat array to include FRG2 and DUX4c was reported in some families with FSHD [53] suggesting that neither gene could cause the disease. A transvection effect resulting from a misbalance of chromatin and transcription factors at 4q35 and unrelated loci following the deletion [12] was proposed to explain that the FRG2 mRNA expressed in FSHD myoblasts originated mostly from the homologous FRG2 gene on chromosome 10, not 4 [16]. A similar mechanism in trans might also occur between the two chromosome 4 alleles in FSHD cells, activating DUX4c on the non-affected one. This could be tested in muscle biopsies of patients with an extended 4q35 deletion removing DUX4c on one allele. Nevertheless, in most affected families, both DUX4c and FRG2 are present and could contribute to the penetrance and severity of the disease. Alternatively, since we found DUX4c expression in control myoblasts and muscle biopsies, it is possible that a single allele deletion could also have pathological consequences.
###end p 57
###begin p 58
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Beckers1">[33]</xref>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX</italic>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Booth1">[35]</xref>
###xml 592 595 592 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX</italic>
###xml 666 670 666 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Kirsch1">[34]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Schmidt1">[54]</xref>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX1</italic>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Ding1">[29]</xref>
###xml 900 904 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-CastilloDavis1">[55]</xref>
###xml 906 910 906 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dmitriev1">[56]</xref>
###xml 250 255 <span type="species:ncbi:9606">human</span>
We have demonstrated functionality of the DUX4c gene in spite of a variant TATAA box, an intron-less ORF and the lack of a poly-A addition signal. If the other 3.3-kb repeated elements scattered on other chromosomes could similarly be expressed, the human genome might have to be expanded with hundreds of additional DUX genes. We have previously characterized other actively transcribed DUX genes on the acrocentric chromosomes [33]. One DUX gene with introns was proposed to have generated multiple retrotransposed pseudogenes with reported EST on autosomal chromosomes [35]. Four putative DUX genes were reported in the pericentromeric region of the Y chromosome [34], [54]. Together with our protein expression data on DUX4 and DUX1[21], [29] this result bears on the general questions of how to define a gene versus a pseudogene, and of what can be considered as junk or "func" (functional) DNA [55], [56].
###end p 58
###begin p 59
###xml 225 229 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Bosnakovski1">[23]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Pandya1">[57]</xref>
###xml 501 505 501 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Hanel1">[19]</xref>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Wuebbles1">[58]</xref>
###xml 939 947 <span type="species:ncbi:9606">patients</span>
FSHD is a complex disease associated with a chromatin change affecting the expression of several genes. However to date only two proteins (i.e. ANT1 and DUX4) were shown to be up-regulated from FSHD candidate genes. Although DUX4 activation strikingly recapitulates key features of the FSHD molecular phenotype [21], [23], other 4q35 genes could also contribute to the heterogeneity of the FSHD phenotype [57]. This could be the case for FRG1 that is implicated in muscle development and angiogenesis [19], [58] but at the present time no data on FRG1 protein expression in FSHD muscle is available. The present study demonstrated that the DUX4c protein is over-expressed in FSHD muscle and could therefore contribute to the development of the disease. Moreover, we have uncovered a putative role for DUX4c in muscle regeneration that should be further investigated in injured or atrophic muscles of healthy individuals, and in muscles of patients with different neuro-muscular pathologies.
###end p 59
###begin title 60
Materials and Methods
###end title 60
###begin title 61
Ethics Statement
###end title 61
###begin p 62
###xml 34 42 34 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s004">Table S2</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-LaoudjChenivesse1">[41]</xref>
Muscle biopsies (see Supplemental Table S2) were performed according to a procedure approved either by the University of Rochester Research Subjects Review Board (reference number RSRB#8567) or current ethical and legislative rules of France as described [41] (ref number 050503). Written informed consent was obtained from all subjects, as directed by the ethical committee of either institution. In addition, the uses of this material have been approved by the ethics committee of the University of Mons-Hainaut (ref number A901).
###end p 62
###begin title 63
Mammalian Cell Cultures
###end title 63
###begin p 64
###xml 177 178 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 311 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-LaoudjChenivesse1">[41]</xref>
###xml 122 126 <span type="species:ncbi:9913">calf</span>
###xml 514 519 <span type="species:ncbi:9796">horse</span>
C2C12 and TE671 cells were grown in DMEM, 1% penicillin/streptomycin/fungizone (Cambrex, Verviers, Belgium) and 10% fetal calf serum (PAA Laboratories) at 37degreesC under 5% CO2. HeLa cells were grown in DMEM-F12 (Cambrex) supplemented as above. The primary myoblast cultures were established as described [41] and grown in DMEM with 10% FCS and 1% Ultroser G (BioSepra, Cergy-Pontoise, France). For differentiation, the cells were either grown to confluence or the medium was replaced by DMEM supplemented by 2% horse serum (PAA laboratories, Pasching, Austria) as indicated. Immortalized myoblasts were grown and differentiated as reported (Zhu et al) except that 1% Ultroser G was used instead of HGF during proliferation.
###end p 64
###begin title 65
Plasmid constructs
###end title 65
###begin p 66
###xml 9 12 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pst</italic>
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eag</italic>
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3</italic>
###xml 158 168 158 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3-DUX4c</italic>
###xml 174 185 174 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3control</italic>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 298 305 298 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pENTR1A</italic>
###xml 343 354 343 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p3 kb-DUX4c</italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pAC1M2</italic>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Chtarto1">[59]</xref>
###xml 460 472 460 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo-DUX4c</italic>
###xml 476 488 476 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pAC1M2-DUX4c</italic>
###xml 570 595 570 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s002">Supporting Information S2</xref>
###xml 194 198 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
A 477-bp PstI/EagI fragment corresponding to the DUX4c promoter was fused to the luciferase reporter gene in pGL3 (Promega, Leiden, The Netherlands) yielding pGL3-DUX4c. The pGL3control has the SV40 promoter/enhancer (Promega). A 3-kb EcoRI fragment containing the DUX4c natural gene was cloned in pENTR1A (Invitrogen, Carlsbad, CA), yielding p3 kb-DUX4c. The 1.2-kb DUX4c ORF was cloned into pCIneo (Promega) or pAC1M2 (for doxycyclin induction [59] yielding pCIneo-DUX4c or pAC1M2-DUX4c. All the constructs were confirmed by sequence determination and are detailed in Supporting Information S2.
###end p 66
###begin title 67
Transient luciferase expression
###end title 67
###begin p 68
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 185 194 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phRL-SV40</italic>
###xml 552 556 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3</italic>
###xml 599 609 595 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pGL3-Basic</italic>
###xml 616 621 612 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 625 629 621 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4</italic>
###xml 639 643 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Gabriels1">[18]</xref>
###xml 765 770 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 891 904 887 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(pGL3-Control</italic>
###xml 190 194 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 868 872 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Either 105 C2C12, 2x105 TE671 or 4x105 HeLa cells were seeded in each well of 6-well plates and grown overnight. Transfections were performed with 1.6 microg reporter plasmid and 16 ng phRL-SV40 (internal control) per well with either FuGENE6 (Roche Diagnostics, Mannheim, Germany) for TE671 cells or Lipofectamin2000 (Invitrogen) for C2C12 and HeLa cells. Cells were lysed 24 h later with the dual luciferase assay system (Promega) and activity measured on a Packard LumiCount (PerkinElmer). The firefly luciferase reporter plasmids were derived from pGL3 (Promega) and contained either no insert (pGL3-Basic), the DUX4c or DUX4 promoter [18]. Experiments were done 3 times in triplicate with 2 different preparations for each plasmid (n = 18 for each point). The DUX4c promoter was about 40- and 350-fold less active in muscle and HeLa cells, respectively, than the SV40 promoter/enhancer (pGL3-Control, not shown).
###end p 68
###begin title 69
RT-PCR, 5' and 3' RACE
###end title 69
###begin p 70
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 190 198 186 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s003">Table S1</xref>
###xml 275 279 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007482-Dixit1">[21]</xref>
###xml 805 810 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUX4c</italic>
###xml 924 928 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCR4</italic>
###xml 969 976 909 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 969 976 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Total RNA was extracted and DNase-treated as described previously [21]. RT was done on 2.5 microg freshly prepared RNA with primer # 167 (all the primers sequences are given in Supplemental Table S1) and 200 U of SuperScript III with a procedure for high secondary structure [21]. 8 microl cDNA were used for PCR with primers # 49 and # 167 and the conditions were 3 min at 94degreesC, followed by 1 min at 94degreesC, 1 min at 68degreesC with a 1degreesC decrease at each cycle, and 2 min at 68degreesC for 4 cycles, followed by 31 cycles of 1 min at 94degreesC, 1 min at 64degreesC, 2 min at 68degreesC with 5 sec/cycle increment during elongation. The RT step of the 5' and 3' RACE was performed with 10 or 2 microg of total DNase-treated RNA, respectively, with the RLM-RACE kit (Ambion, Austin, TX). DUX4c primers #68 and #73 (5'RACE) or #350 and #351 (3'RACE) were used for the nested PCR. The products were cloned in pCR4 (TOPO TA kit, Invitrogen), amplified in E. coli and sequenced with the CEQ 2000 (Beckman Coulter).
###end p 70
###begin title 71
Antibodies against DUX4c
###end title 71
###begin p 72
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s006">Fig. S2</xref>
###xml 2 8 <span type="species:ncbi:9986">rabbit</span>
###xml 252 259 <span type="species:ncbi:9986">rabbits</span>
A rabbit antiserum was raised against a 16-residue peptide (underlined in Supplemental Fig. S2) specific of the DUX4c carboxyl-terminal domain. This peptide was chosen by accessibility prediction programs, synthesized, coupled to KLH and injected into rabbits. The resulting antisera were purified by affinity chromatography on the immobilized peptide (Eurogentec, Seraing, Belgium).
###end p 72
###begin title 73
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Transcription/translation in vitro
###end title 73
###begin p 74
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 124 126 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 12 18 <span type="species:ncbi:9986">rabbit</span>
Aliquots of rabbit reticulocyte lysate (TNT kit, Promega) were incubated with pCIneo vectors in the presence of 30 microCi [35S]-cysteine (Amersham Biosciences, Roosendaal, The Netherlands) and T7 RNA polymerase. 10 microl of the products were denatured in XT sample buffer with reducing agent (Bio-Rad, Hercules, CA) and analysed by PAGE-SDS. The gel was incubated 30 min in Amplify (Amersham Biosciences), air dried and submitted to autoradiography.
###end p 74
###begin title 75
Western blot
###end title 75
###begin p 76
###xml 341 347 <span type="species:ncbi:9986">rabbit</span>
Whole cell extracts of myoblast primary cultures were obtained by lysis in 50 mM Tris pH 7.0, 50 mM NaCl, 0.1% Nonidet P40, 1 mM DTT and protease inhibitors, were separated by PAGE-SDS and electrotransferred onto a PVDF or nitrocellulose membrane according to the manufacturer (Amersham Biosciences). The Western blot was incubated with the rabbit anti-DUX4c (1:1000) or anti-Myf5 (1:500, C-20, Santa Cruz Biotechnology, Santa Cruz, CA) sera followed by secondary antibodies coupled to HRP and the ECL kit (Amersham Biosciences).
###end p 76
###begin p 77
###xml 196 202 <span type="species:ncbi:9986">rabbit</span>
###xml 240 246 <span type="species:ncbi:9986">rabbit</span>
###xml 290 296 <span type="species:ncbi:9986">rabbit</span>
For standardization, the membranes were stripped and immunostaining was performed with primary antibodies raised against either alpha-tubulin (mAb, Sigma-Aldrich, Saint Louis, MO), pan-cadherins (rabbit serum, Sigma-Aldrich), cytochrome C (rabbit serum, Santa Cruz Biotechnology) or actin (rabbit serum, Sigma-Aldrich) as indicated.
###end p 77
###begin title 78
Co-immunoprecipitation
###end title 78
###begin p 79
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo</italic>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
###xml 429 435 <span type="species:ncbi:9986">rabbit</span>
1.5x106 TE671 cells were seeded in a 75-cm2 flask, grown and transfected with pCIneo plasmids. Whole cell extracts were prepared 24 h later using sonication in 500 microl lysis buffer follow by centrifugation 5 min at 16.000 g to discard cell membranes. Immunoprecipitation was performed on 800 microg total extract with the mouse monoclonal 9A12 antibody directed against DUX4 and cross-reacting with DUX4c (1:5, Dixit 2007) or rabbit anti-MYF5 (1:100, Santa Cruz Biotechnologies) serum in 1 ml IP buffer in the presence of protein G-agarose (Fermentas) or protein A-Sepharose (Amersham Biosciences) respectively as described by the manufacturers. The final pellet was heated 5 min at 95degreesC in 30 microl loading buffer with reducing agent (Fermentas), and centrifuged 5 min at 16,000 g. The supernatant was analysed by 12% PAGE-SDS followed by electrotransfer to a PVDF membrane as above, and Western blot was performed with the anti-MYF5 serum (1:500) or the 9A12 antibody (1:1000) followed by secondary antibodies coupled to HRP (Amersham Biosciences) and revealed as above.
###end p 79
###begin title 80
Immunofluorescence
###end title 80
###begin p 81
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 283 308 279 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s002">Supporting Information S2</xref>
###xml 983 987 <span type="species:ncbi:9925">goat</span>
###xml 993 998 <span type="species:ncbi:10090">mouse</span>
###xml 1012 1018 <span type="species:ncbi:9986">rabbit</span>
1.5x105 TE671 cells were seeded on coverslips in 6-well plates and transfected 24 h later with 1 microg plasmid DNA as indicated. After 24 h, the cells were fixed in 4% paraformaldehyde or Carnoy (desmin detection). Immunostaining was performed by standard procedures as detailed in Supporting Information S2 with anti-DUX4c (1:50) or anti-PCNA (PC10, 1:40, Dako, Glostrup, Denmark) serum or anti-desmin (DE-R-11, 1:50, Dako) or anti-cyclin A (1:50, BD Transduction Laboratories, Erembodegem, Belgium) antibodies. As a control, the anti-DUX4c serum was preincubated 2 h with a 5-fold molar excess of the DUX4c immunogenic peptide. The anti-IgG secondary antibodies were either coupled to FITC or biotinylated (Dako, Amersham Biosciences) and incubated with streptavidin-Texas-Red (Vector Laboratories, Burlingame, CA). The primary myoblasts (on collagen-coated dishes) were incubated with anti-DUX4c and anti-troponin T (1:100, JLT-12, Sigma) followed by Alexa secondary antibodies (goat anti-mouse 488 and anti-rabbit 555, Invitrogen).
###end p 81
###begin title 82
Proliferation assay
###end title 82
###begin p 83
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
1.5x105 TE671 cells were seeded in 6-well plates, grown overnight and transfected with 1 microg plasmid DNA. The CellTiter 96 non-radioactive cell proliferation assay (Promega) was used 24 or 48 hours after transfection as described by the manufacturer. Experiments were done in triplicate.
###end p 83
###begin title 84
Myogenic factor activities
###end title 84
###begin p 85
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 105 115 101 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCIneo-DUX</italic>
###xml 197 222 193 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007482.s002">Supporting Information S2</xref>
###xml 357 363 <span type="species:ncbi:9986">rabbit</span>
1.2x106 TE671 cells were seeded in a 75-cm2 flask, grown overnight, transfected with 10 microg of either pCIneo-DUX plasmid and collected 48 h later. The cell lysates were prepared as described in Supporting Information S2 and were deposited on an ELISA plate where a specific DNA target was immobilized (TransAm kit, ActiveMotif, Carlsbad, CA). A specific rabbit antiserum was added, followed by a secondary antibody coupled to HRP, and a substrate yielding a product with absorbance at 450 nm.
###end p 85
###begin title 86
Statistical analyses
###end title 86
###begin p 87
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Statistical significance was evaluated by the Student t test.
###end p 87
###begin title 88
Supporting Information
###end title 88
###begin p 89
Supplemental data
###end p 89
###begin p 90
(0.05 MB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
Supporting Materials and Methods
###end p 92
###begin p 93
(0.04 MB DOC)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
Primer sequences
###end p 95
###begin p 96
(0.06 MB DOC)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
Biopsies and myoblast lines.
###end p 98
###begin p 99
(0.05 MB DOC)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
Characterization of DUX4c mRNA in transfected cells. Alignment of the DUX4c and DUX4 promoter sequences (GenBank accession nos AY500824 and AF117653). The numberings start at the 5'EcoRI sites. The variant TATAA boxes are underlined with brackets, the putative E boxes double underlined, the GC boxes are boxed, and the translation initiation codons circled. The broken arrows indicate the transcription start sites experimentally determined for DUX4 (CoppA(c)e et al, 2004) and DUX4c. The later ones were identified by 5'RACE on RNA extracted from C2C12 cells transfected with p3 kb-DUX4c (a) and p7.5 kb-DUX4c (b). At each start site, the consensus initiator sequences is shown in low cases (c/t c a n t/a c/t c/t). The primers (dotted line) used in a chromatin immunoprecipitation study of acetylated histone H4 in 4q35 (Jiang et al, 2003) map in DUX4c.
###end p 101
###begin p 102
(1.38 MB TIF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 492 498 <span type="species:ncbi:9986">rabbit</span>
Sequence alignment of the DUX4c and DUX4 proteins. The DUX4c protein sequence was derived from pSK-DUX4c (integrating variations mentioned in GenBank accession no. AY500824) and the DUX4 protein from GenBank #AF117653. The identical double homeodomains are boxed. The arrows indicate polymorphic residues: either valine or isoleucine at position 229 in both DUX4c and DUX4; either alanine or proline at position 272 in DUX4c, but only proline in DUX4. The peptide used to generate a specific rabbit antiserum against DUX4c is underlined.
###end p 104
###begin p 105
(2.56 MB TIF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 529 534 529 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007482-g003">Fig 3</xref>
###xml 55 60 <span type="species:ncbi:9606">Human</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 495 501 <span type="species:ncbi:9986">rabbit</span>
Downregulation of DUX4c expression by a RNA silencing. Human muscle TE671 cells were transfected (siPORT NeoFX, Ambion) or not (-) with 20 nmol of siRNA either targeting the DUX4c 3'UTR, an unrelated genomic sequence (unrl), or a sequence not found in the human genome (negative control, n.c.) (Ambion). They were either transfected 5 h later (Fugene 6) with the pCIneo-DUX4c expression vector (DUX4c) or not (NT). Protein extracts were prepared 72 h later and analysed by Western blot with the rabbit anti-DUX4c antiserum as in Fig 3. Actin (antibody from Sigma) was used as a loading control.
###end p 107
###begin p 108
(2.71 MB TIF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 256 261 <span type="species:ncbi:9606">human</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
We thank J.E. Hewitt (University of Nottingham, United Kingdom), and S.M. Van der Maarel (University of Leiden, The Netherlands) for genomic clones, L. Tenenbaum and A. Chtarto (University of Brussels, ULB, Belgium) for the pAC1M2 vector, the platform for human cell culture from the Institute of Myology (Paris, France) for the immortalized myoblasts. We thank the patients for muscle biopsies, and the "Amis FSH Europe" for their constant support.
###end p 110
###begin title 111
References
###end title 111
###begin article-title 112
Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy.
###end article-title 112
###begin article-title 113
The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes.
###end article-title 113
###begin article-title 114
Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.
###end article-title 114
###begin article-title 115
Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) [published erratum appears in Hum Mol Genet 1995 Jul;4(7):1243-4].
###end article-title 115
###begin article-title 116
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype.
###end article-title 116
###begin article-title 117
Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.
###end article-title 117
###begin article-title 118
Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
###end article-title 118
###begin article-title 119
Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis.
###end article-title 119
###begin article-title 120
Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy.
###end article-title 120
###begin article-title 121
Specific Sequence Variations within the 4q35 Region Are Associated with Facioscapulohumeral Muscular Dystrophy.
###end article-title 121
###begin article-title 122
Facioscapulohumeral muscular dystrophy.
###end article-title 122
###begin article-title 123
The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy.
###end article-title 123
###begin article-title 124
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts.
###end article-title 124
###begin article-title 125
###xml 64 69 <span type="species:ncbi:9606">human</span>
Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35.
###end article-title 125
###begin article-title 126
Identification of a novel beta-tubulin subfamily with one member (TUBB4Q) located near the telomere of chromosome region 4q35.
###end article-title 126
###begin article-title 127
###xml 116 124 <span type="species:ncbi:9606">patients</span>
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
###end article-title 127
###begin article-title 128
A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: Implications for the facio-scapulo-humeral dystrophy.
###end article-title 128
###begin article-title 129
###xml 61 68 <span type="species:ncbi:9606">patient</span>
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element.
###end article-title 129
###begin article-title 130
Muscular dystrophy candidate gene FRG1 is critical for muscle development.
###end article-title 130
###begin article-title 131
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1.
###end article-title 131
###begin article-title 132
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.
###end article-title 132
###begin article-title 133
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein.
###end article-title 133
###begin article-title 134
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies.
###end article-title 134
###begin article-title 135
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Characterization of a tet-repressible muscle-specific Pitx1 transgenic mouse model as an animal model of FSHD.
###end article-title 135
###begin article-title 136
Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy.
###end article-title 136
###begin article-title 137
Fine mapping of the FSHD gene region orientates the rearranged fragment detected by the probe p13E-11.
###end article-title 137
###begin article-title 138
###xml 20 25 <span type="species:ncbi:9606">human</span>
Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.
###end article-title 138
###begin article-title 139
DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation.
###end article-title 139
###begin article-title 140
Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements.
###end article-title 140
###begin article-title 141
Skeletal muscle progenitor cells and the role of Pax genes.
###end article-title 141
###begin article-title 142
Molecular regulation of satellite cell function.
###end article-title 142
###begin article-title 143
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies.
###end article-title 143
###begin article-title 144
Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements.
###end article-title 144
###begin article-title 145
###xml 77 82 <span type="species:ncbi:9606">human</span>
Interchromosomal segmental duplications of the pericentromeric region on the human Y chromosome.
###end article-title 145
###begin article-title 146
###xml 85 90 <span type="species:ncbi:9606">human</span>
Annotation, nomenclature and evolution of four novel homeobox genes expressed in the human germ line.
###end article-title 146
###begin article-title 147
Testing the position effect variegation hypothesis for facioscapulohumeral dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
###end article-title 147
###begin article-title 148
RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA.
###end article-title 148
###begin article-title 149
A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.
###end article-title 149
###begin article-title 150
Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle.
###end article-title 150
###begin article-title 151
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
###end article-title 151
###begin article-title 152
Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle.
###end article-title 152
###begin article-title 153
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
###end article-title 153
###begin article-title 154
###xml 49 56 <span type="species:ncbi:9606">patient</span>
Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes.
###end article-title 154
###begin article-title 155
The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.
###end article-title 155
###begin article-title 156
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
Exogenous hepatocyte growth factor inhibits myoblast differentiation by inducing myf5 expression and suppressing myoD expression in an organ culture system of embryonic mouse tongue.
###end article-title 156
###begin article-title 157
Multiple phosphorylation events control mitotic degradation of the muscle transcription factor Myf5.
###end article-title 157
###begin article-title 158
A role for the myogenic determination gene Myf5 in adult regenerative myogenesis.
###end article-title 158
###begin article-title 159
The myogenic factor Myf5 supports efficient skeletal muscle regeneration by enabling transient myoblast amplification.
###end article-title 159
###begin article-title 160
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle.
###end article-title 160
###begin article-title 161
###xml 74 81 <span type="species:ncbi:8355">Xenopus</span>
Localization of Myf-5, MRF4 and alpha cardiac actin mRNAs in regenerating Xenopus skeletal muscle.
###end article-title 161
###begin article-title 162
The DUX gene family and FSHD.
###end article-title 162
###begin article-title 163
Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.
###end article-title 163
###begin article-title 164
D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection.
###end article-title 164
###begin article-title 165
Complex evolution of a Y-chromosomal double homeobox 4 (DUX4)-related gene family in hominoids.
###end article-title 165
###begin article-title 166
The evolution of noncoding DNA: how much junk, how much func?
###end article-title 166
###begin article-title 167
Pearls in the junk: dissecting the molecular pathogenesis of facioscapulohumeral muscular dystrophy.
###end article-title 167
###begin article-title 168
Facioscapulohumeral dystrophy.
###end article-title 168
###begin article-title 169
FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
###end article-title 169
###begin article-title 170
Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
###end article-title 170
###begin article-title 171
Exclusion of muscle specific actinin-associated LIM protein (ALP) gene from 4q35 facioscapulohumeral muscular dystrophy (FSHD) candidate genes.
###end article-title 171
###begin p 172
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 172
###begin p 173
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was funded by the ABMM (Belgium; A.B.), AFM (France; A.B. #8598 and D. L-C. AFM-CNRS), F.N.R.S. (Belgium; A.B. #3.4623.01), FSH Society (A.B. #DR-01) and MDA (A.B. # 3209 and F.C. # 3453). Additional support of the Fischer-Shaw Family (USA; A.B.) and Mr. D. Frenzel (Germany; A.B.). E.A., A.M. and A.T. held pre-doctoral fellowships of the FRIA (Belgium), S.S. of the AFM, and M.B. of the MRT (France). D. L-C. and I.L. were AFM post-doctoral fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 173

